InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.26
(
-0.25%
)
Bitcoin
61,110.65
(
0.48%
)
Post# of 13959
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Investor100

Send PM Follow Ignore
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Investor100

Re: Investor100 post# 1274

Tuesday, 12/06/2016 4:59:53 PM

Tuesday, December 06, 2016 4:59:53 PM

Post# of 13959
Immune Pharmaceuticals Announces Immuno-Oncology R&D Update on December 8, 2016

Have my seat with popcorn!

http://finance.yahoo.com/news/immune-pharmaceuticals-announces-immuno-oncology-140000904.html

NEW YORK, Nov. 22, 2016 /PRNewswire/ -- Immune Pharmaceuticals (IMNP) (Immune) announced today that it will hold an Immuno-Oncology R&D Update for investors on December 8, 2016 in New York City. Immune management and several Oncology Key Opinion leaders will review development plans and milestones for Ceplene® and other pipeline assets to be funded separately in the recently announced Immune subsidiary, Cytovia Oncology.

Investor 100
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up